CYP2A13 expressed in human bladder metabolically activates 4‐aminobiphenyl

M Nakajima, M Itoh, H Sakai, T Fukami… - … journal of cancer, 2006 - Wiley Online Library
Cigarette smoking is the predominant risk factor for bladder cancer. Aromatic amines such
as 4‐aminobiphenyl (ABP) is the major carcinogens found in tobacco smoke. Although it is …

4-aminobiphenyl–induced liver and urinary bladder DNA adduct formation in Cyp1a2 (–/–) and Cyp1a2 (+/+) mice

Y Tsuneoka, TP Dalton, ML Miller… - Journal of the …, 2003 - academic.oup.com
Background: Metabolites of the potent human carcinogen 4-aminobiphenyl (ABP) induce
oxidative stress and form DNA adducts that are associated with hepatic and urinary bladder …

CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice

S Kimura, M Kawabe, JM Ward, H Morishima… - …, 1999 - academic.oup.com
Aminobiphenyl (4-ABP), a potent carcinogen in rodents (liver cancer) and human (bladder
cancer), is found as an environmental contaminant and in tobacco smoke. Hemoglobin …

Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa

S Imaoka, Y Yoneda, T Matsnda, M Degawa… - Biochemical …, 1997 - Elsevier
We investigated the mutagenic activation of 2-naphthylamine (2-NA), 3, 2′-dimethyl-4-
aminobiphenyl (DMAB), and 3, 3′-dichlorobenzidine (DCB), bladder carcinogens, by renal …

Cytochrome P450 CYP3A in human renal cell cancer

GI Murray, MCE McFadyen, RT Mitchell… - British journal of …, 1999 - nature.com
Renal cell cancer is the main malignant tumour of the kidney and has an increasing
incidence. This type of tumour has a poor prognosis and shows intrinsic resistance to …

CYP4B1 is a possible risk factor for bladder cancer in humans

S Imaoka, Y Yoneda, T Sugimoto, T Hiroi… - Biochemical and …, 2000 - Elsevier
In experimental animals such as rats and rabbits, CYP4B1 has an important role in
mutagenic activation of procarcinogens in bladders. In human bladders, it is not clear …

Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study

L Tao, YB Xiang, KK Chan, R Wang… - … journal of cancer, 2012 - Wiley Online Library
Abstract Cytochrome P450 1A2 (CYP1A2) is hypothesized to catalyze the activation of
arylamines, known human bladder carcinogens present in cigarette smoke. The relationship …

CYP1A2 is expressed along with CYP1A1 in the human lung

C Wei, RJ Cacavale, JJ Kehoe, PE Thomas, MM Iba - Cancer letters, 2001 - Elsevier
The expression and activity of CYP1A1 were examined in fresh, small-sized lung biopsy
specimens from nine human subjects. CYP1A1 transcripts were detected by reverse …

Evaluation of Time Dependence and Interindividual Differences in Benzo[a]pyrene-Mediated CYP1A1 Induction and Genotoxicity in Porcine Urinary Bladder Cell …

S Plöttner, A Borza, A Wolf, HM Bolt… - Journal of Toxicology …, 2008 - Taylor & Francis
Exposure to tobacco smoke is an established cause of cancer in humans and cigarette
smoking is a risk factor for urinary bladder cancer development. Aromatic amines are …

CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody

LR Zhu, PE Thomas, G Lu, KR Reuhl, GY Yang… - Drug metabolism and …, 2006 - ASPET
Human cytochrome P450 2A13 (CYP2A13) is highly efficient in the metabolic activation of a
tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and …